TRV-2026-1264Certified recordPeer-reviewed

Person-Based Progression in Acute Myeloid Leukemia Classification: A Multi-View Convolutional Neural Network Approach

Acute myeloid leukemia (AML) is a hematologic malignancy in which accurate subtype identification is important for treatment planning and prognosis. This study developed a deep learning approach for AML subtype classification using multiple single-cell images from each patient rather than conventional instance-based classification. An open-source dataset containing 81,214 single-cell images from 189 individuals was analyzed. The dataset included four genetically defined AML subtypes and a healthy control group.…

Health · Good Space — documented gain · certified 2026-10-03 · v1 · article view · machine-readable

Current reading — gain

Patient-level 500-view convolutional neural network improved acute myeloid leukemia subtype classification, achieving 0.8783 accuracy and 0.8622 F1 score compared to single-view analysis.

Evidence

Reader signal

How should this claim be treated?

Cite this record

Truvace Impact Record TRV-2026-1264, v1: “Person-Based Progression in Acute Myeloid Leukemia Classification: A Multi-View Convolutional Neural Network Approach.” Truvace, 2026-10-03. /record/TRV-2026-1264 (accessed at citation time). sha256 d6fa1bad5f79cb07…

Calibration history

Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.

  1. Certifiedv1d6fa1bad5f79…

    Certified into the record

Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-1264 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.